| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 6.30e-05 | 11 | 148 | 3 | GO:0098973 | |
| GeneOntologyMolecularFunction | actin binding | MYH3 MYH4 NEBL MYO5A GSN AFAP1 DST XIRP2 SYNE2 FHDC1 DIAPH3 MYBPC1 | 2.42e-04 | 479 | 148 | 12 | GO:0003779 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 3.00e-04 | 18 | 148 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 3.24e-04 | 4 | 148 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH3 MYH4 NSF NAIP KATNA1 MORC2 SMC5 TRAP1 ENTPD1 HSP90AB2P DNAH8 | 4.58e-04 | 441 | 148 | 11 | GO:0016887 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.42e-05 | 153 | 147 | 8 | GO:0030048 | |
| GeneOntologyBiologicalProcess | response to alkaloid | 3.20e-05 | 125 | 147 | 7 | GO:0043279 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 5.61e-05 | 11 | 147 | 3 | GO:0071313 | |
| GeneOntologyBiologicalProcess | organelle assembly | CFAP47 MYH3 GBF1 NEBL DISC1 TTC39C ZNF423 VTA1 GSN PTK2B FBXO5 SYNE2 POC1B SNX18 PRKDC FHDC1 DIAPH3 CEP126 DNAH8 KNL1 MYBPC1 | 5.80e-05 | 1138 | 147 | 21 | GO:0070925 |
| GeneOntologyCellularComponent | sarcomere | CACNA1S MYH3 MYH4 ANK1 NEBL RYR1 RYR2 DST XIRP2 SYNE2 MYBPC1 | 1.46e-06 | 249 | 146 | 11 | GO:0030017 |
| GeneOntologyCellularComponent | supramolecular fiber | CACNA1S MYH3 MYH4 ANK1 NEBL MYO5A DISC1 POTEF KATNA1 DNAH14 RYR1 RYR2 GSN TTLL7 POTEE AFAP1 DST XIRP2 SYNE2 FHDC1 DIAPH3 POTEI DNAH8 MYBPC1 | 2.17e-06 | 1179 | 146 | 24 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CACNA1S MYH3 MYH4 ANK1 NEBL MYO5A DISC1 POTEF KATNA1 DNAH14 RYR1 RYR2 GSN TTLL7 POTEE AFAP1 DST XIRP2 SYNE2 FHDC1 DIAPH3 POTEI DNAH8 MYBPC1 | 2.44e-06 | 1187 | 146 | 24 | GO:0099081 |
| GeneOntologyCellularComponent | myofibril | CACNA1S MYH3 MYH4 ANK1 NEBL RYR1 RYR2 DST XIRP2 SYNE2 MYBPC1 | 3.56e-06 | 273 | 146 | 11 | GO:0030016 |
| GeneOntologyCellularComponent | contractile muscle fiber | CACNA1S MYH3 MYH4 ANK1 NEBL RYR1 RYR2 DST XIRP2 SYNE2 MYBPC1 | 6.32e-06 | 290 | 146 | 11 | GO:0043292 |
| GeneOntologyCellularComponent | I band | 2.22e-05 | 166 | 146 | 8 | GO:0031674 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH3 MYH4 NEBL MYO5A POTEF CAPN2 GSN POTEE AFAP1 DST XIRP2 FHDC1 DIAPH3 POTEI | 5.34e-05 | 576 | 146 | 14 | GO:0015629 |
| GeneOntologyCellularComponent | actin filament | 7.58e-05 | 146 | 146 | 7 | GO:0005884 | |
| GeneOntologyCellularComponent | Z disc | 9.36e-05 | 151 | 146 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | sarcoplasm | 1.50e-04 | 114 | 146 | 6 | GO:0016528 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 3.82e-04 | 88 | 146 | 5 | GO:0016529 | |
| GeneOntologyCellularComponent | A band | 4.76e-04 | 52 | 146 | 4 | GO:0031672 | |
| GeneOntologyCellularComponent | myosin filament | 6.86e-04 | 25 | 146 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | perinuclear endoplasmic reticulum | 1.07e-03 | 29 | 146 | 3 | GO:0097038 | |
| GeneOntologyCellularComponent | cell cortex | 1.21e-03 | 371 | 146 | 9 | GO:0005938 | |
| GeneOntologyCellularComponent | cation channel complex | 1.34e-03 | 235 | 146 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.38e-03 | 378 | 146 | 9 | GO:0034702 | |
| GeneOntologyCellularComponent | actomyosin | 1.39e-03 | 117 | 146 | 5 | GO:0042641 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 1.43e-03 | 32 | 146 | 3 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 1.43e-03 | 32 | 146 | 3 | GO:0043189 | |
| GeneOntologyCellularComponent | actin filament bundle | 1.44e-03 | 118 | 146 | 5 | GO:0032432 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 1.93e-03 | 185 | 146 | 6 | GO:0009898 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 2.10e-03 | 10 | 146 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | neuronal cell body | TRPV1 MYO5A FRMD7 CAPN2 NAIP KATNA1 KCNB2 TTLL7 PTK2B AKAP9 UCHL1 ENTPD1 SNX18 ASTN2 | 2.17e-03 | 835 | 146 | 14 | GO:0043025 |
| GeneOntologyCellularComponent | cell body | TRPV1 MYO5A DISC1 FRMD7 CAPN2 NAIP KATNA1 KCNB2 TTLL7 PTK2B AKAP9 UCHL1 ENTPD1 SNX18 ASTN2 | 2.18e-03 | 929 | 146 | 15 | GO:0044297 |
| GeneOntologyCellularComponent | chromosomal region | 2.86e-03 | 421 | 146 | 9 | GO:0098687 | |
| HumanPheno | Muscle spasm | 3.99e-06 | 4 | 52 | 3 | HP:0031988 | |
| HumanPheno | Intermittent painful muscle spasms | 3.99e-06 | 4 | 52 | 3 | HP:0011964 | |
| HumanPheno | High-output congestive heart failure | 1.96e-05 | 6 | 52 | 3 | HP:0001722 | |
| MousePheno | abnormal muscle electrophysiology | 4.68e-06 | 32 | 110 | 5 | MP:0004145 | |
| MousePheno | impaired skeletal muscle contractility | 2.34e-05 | 44 | 110 | 5 | MP:0002841 | |
| MousePheno | abnormal sarcoplasmic reticulum morphology | 2.86e-05 | 23 | 110 | 4 | MP:0004088 | |
| Domain | - | 1.57e-06 | 4 | 138 | 3 | 3.90.1460.10 | |
| Domain | GTF2I | 1.57e-06 | 4 | 138 | 3 | PS51139 | |
| Domain | GTF2I | 1.57e-06 | 4 | 138 | 3 | PF02946 | |
| Domain | GTF2I | 1.57e-06 | 4 | 138 | 3 | IPR004212 | |
| Domain | - | TRPV1 GLS2 ANK1 POTEF BCORL1 POTEE TRANK1 ANKRD13C ANKRD18A ANKRD12 POTEI | 2.37e-06 | 248 | 138 | 11 | 1.25.40.20 |
| Domain | ANK | TRPV1 GLS2 ANK1 POTEF BCORL1 POTEE TRANK1 ANKRD13C ANKRD18A ANKRD12 POTEI | 2.66e-06 | 251 | 138 | 11 | SM00248 |
| Domain | ANK_REPEAT | TRPV1 GLS2 ANK1 POTEF BCORL1 POTEE TRANK1 ANKRD13C ANKRD18A ANKRD12 POTEI | 2.87e-06 | 253 | 138 | 11 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | TRPV1 GLS2 ANK1 POTEF BCORL1 POTEE TRANK1 ANKRD13C ANKRD18A ANKRD12 POTEI | 2.98e-06 | 254 | 138 | 11 | IPR020683 |
| Domain | ANK_REP_REGION | TRPV1 GLS2 ANK1 POTEF BCORL1 POTEE TRANK1 ANKRD13C ANKRD18A ANKRD12 POTEI | 2.98e-06 | 254 | 138 | 11 | PS50297 |
| Domain | Ankyrin_rpt | TRPV1 GLS2 ANK1 POTEF BCORL1 POTEE TRANK1 ANKRD13C ANKRD18A ANKRD12 POTEI | 4.01e-06 | 262 | 138 | 11 | IPR002110 |
| Domain | Ank_2 | TRPV1 GLS2 ANK1 POTEF BCORL1 POTEE ANKRD13C ANKRD18A ANKRD12 POTEI | 4.55e-06 | 215 | 138 | 10 | PF12796 |
| Domain | Ank | TRPV1 GLS2 ANK1 POTEF BCORL1 POTEE ANKRD13C ANKRD18A ANKRD12 POTEI | 7.64e-06 | 228 | 138 | 10 | PF00023 |
| Domain | Ryanodine_rcpt | 1.62e-04 | 3 | 138 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 1.62e-04 | 3 | 138 | 2 | IPR009460 | |
| Domain | RyR | 1.62e-04 | 3 | 138 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 1.62e-04 | 3 | 138 | 2 | PF06459 | |
| Domain | Ryan_recept | 1.62e-04 | 3 | 138 | 2 | IPR013333 | |
| Domain | Actin_CS | 2.06e-04 | 16 | 138 | 3 | IPR004001 | |
| Domain | ACTINS_2 | 2.49e-04 | 17 | 138 | 3 | PS00432 | |
| Domain | Actin/actin-like_CS | 2.97e-04 | 18 | 138 | 3 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 3.51e-04 | 19 | 138 | 3 | PS01132 | |
| Domain | - | 4.10e-04 | 20 | 138 | 3 | 3.30.565.10 | |
| Domain | HATPase_C | 4.76e-04 | 21 | 138 | 3 | IPR003594 | |
| Domain | DUF3669_Znf | 7.97e-04 | 6 | 138 | 2 | IPR022137 | |
| Domain | RIH_assoc-dom | 7.97e-04 | 6 | 138 | 2 | IPR013662 | |
| Domain | DUF3669 | 7.97e-04 | 6 | 138 | 2 | PF12417 | |
| Domain | Ins145_P3_rec | 7.97e-04 | 6 | 138 | 2 | PF08709 | |
| Domain | RIH_assoc | 7.97e-04 | 6 | 138 | 2 | PF08454 | |
| Domain | RIH_dom | 7.97e-04 | 6 | 138 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 7.97e-04 | 6 | 138 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 7.97e-04 | 6 | 138 | 2 | IPR015925 | |
| Domain | - | 7.97e-04 | 6 | 138 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 7.97e-04 | 6 | 138 | 2 | PF01365 | |
| Domain | Actin | 1.52e-03 | 31 | 138 | 3 | IPR004000 | |
| Domain | Actin | 1.52e-03 | 31 | 138 | 3 | PF00022 | |
| Domain | ACTIN | 1.52e-03 | 31 | 138 | 3 | SM00268 | |
| Domain | Ion_trans_dom | 1.58e-03 | 114 | 138 | 5 | IPR005821 | |
| Domain | Ion_trans | 1.58e-03 | 114 | 138 | 5 | PF00520 | |
| Domain | EF-hand_8 | 2.00e-03 | 34 | 138 | 3 | PF13833 | |
| Domain | RGS | 2.17e-03 | 35 | 138 | 3 | PF00615 | |
| Domain | RGS | 2.17e-03 | 35 | 138 | 3 | SM00315 | |
| Domain | MIR | 2.35e-03 | 10 | 138 | 2 | PF02815 | |
| Domain | MIR_motif | 2.35e-03 | 10 | 138 | 2 | IPR016093 | |
| Domain | MIR | 2.35e-03 | 10 | 138 | 2 | PS50919 | |
| Domain | MIR | 2.35e-03 | 10 | 138 | 2 | SM00472 | |
| Domain | RGS | 2.36e-03 | 36 | 138 | 3 | PS50132 | |
| Domain | Myosin_head_motor_dom | 2.76e-03 | 38 | 138 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.76e-03 | 38 | 138 | 3 | PS51456 | |
| Domain | Myosin_head | 2.76e-03 | 38 | 138 | 3 | PF00063 | |
| Domain | MYSc | 2.76e-03 | 38 | 138 | 3 | SM00242 | |
| Domain | RGS | 2.97e-03 | 39 | 138 | 3 | IPR016137 | |
| Domain | ARM-type_fold | 3.74e-03 | 339 | 138 | 8 | IPR016024 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.65e-03 | 14 | 138 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.65e-03 | 14 | 138 | 2 | IPR024743 | |
| Domain | MT | 4.65e-03 | 14 | 138 | 2 | PF12777 | |
| Domain | AAA_8 | 4.65e-03 | 14 | 138 | 2 | PF12780 | |
| Domain | DHC_fam | 5.34e-03 | 15 | 138 | 2 | IPR026983 | |
| Domain | FH2 | 5.34e-03 | 15 | 138 | 2 | PS51444 | |
| Domain | Dynein_heavy | 5.34e-03 | 15 | 138 | 2 | PF03028 | |
| Domain | FH2_Formin | 5.34e-03 | 15 | 138 | 2 | IPR015425 | |
| Domain | FH2 | 5.34e-03 | 15 | 138 | 2 | PF02181 | |
| Domain | Myosin_N | 5.34e-03 | 15 | 138 | 2 | PF02736 | |
| Domain | Dynein_heavy_dom | 5.34e-03 | 15 | 138 | 2 | IPR004273 | |
| Domain | Myosin_N | 5.34e-03 | 15 | 138 | 2 | IPR004009 | |
| Domain | FH2 | 5.34e-03 | 15 | 138 | 2 | SM00498 | |
| Pubmed | MYH3 MYH4 GLS2 NUP85 MYO5A RBBP8 POTEF GRK5 MYNN SGO1 ZEB2 RYR2 PHEX POTEE PARP1 GTF2IRD2B TRAP1 DST SACS CEBPZ N4BP2 SYNE2 SUPT16H GTF2IRD2 NFXL1 PRKDC DIAPH3 POTEI DNAH8 GOLGB1 CCDC158 MYBPC1 | 1.39e-14 | 1442 | 149 | 32 | 35575683 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | GBF1 MYO5A ACOT9 CC2D1A MORC2 SMC5 GSN TRAP1 SUGP2 CEBPZ BRD9 SNX18 MKI67 NFXL1 DIAPH3 SPATS2 TAF7 NOL8 | 2.42e-09 | 724 | 149 | 18 | 36232890 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NUP85 MYO5A RBBP6 ACOT9 CMAS PDCD4 GSN HARS2 PARP1 TRMT10C AFAP1 GTF2I DST MRPL15 CEBPZ SUPT16H MKI67 UTP20 PRKDC SPATS2 EIF3M NUP153 NOL8 | 4.50e-09 | 1257 | 149 | 23 | 36526897 |
| Pubmed | NEBL MYO5A NSF RBBP6 ORC3 MORC2 CMAS ZNF767P POTEE HARS2 TRMT10C AFAP1 DST CEBPZ GLG1 ARID2 BRD9 CDYL2 UTP20 HSP90AB2P SPATS2 EIF3M GOLGB1 NOL8 | 2.52e-08 | 1497 | 149 | 24 | 31527615 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NEBL RBBP6 CC2D1A PDCD4 BRAP PARP1 TRAP1 GTF2I DST SUGP2 UCHL1 ARID2 MKI67 PRKDC GOLGB1 NUP153 KNL1 NOL8 | 1.16e-07 | 934 | 149 | 18 | 33916271 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYO5A RBBP6 MATN2 EIF2S3B CMAS PDCD4 GSN PARP1 GTF2I DST MRPL15 CEBPZ OSBPL3 BRD9 SUPT16H MKI67 UTP20 PRKDC | 1.47e-07 | 949 | 149 | 18 | 36574265 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MYO5A NSF ACOT9 GSN AKAP9 MRPL15 SUGP2 CEBPZ ZNF746 UTP20 SPATS2 EIF3M GOLGB1 NUP153 NOL8 TGS1 | 1.72e-07 | 754 | 149 | 16 | 33060197 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 2.95e-07 | 271 | 149 | 10 | 32433965 | |
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 23229069 | ||
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 22899722 | ||
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 17823943 | ||
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 21328569 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NUP85 MYO5A NSF GSN PARP1 TRAP1 DST SUGP2 SACS CEBPZ UCHL1 SYNE2 SUPT16H MKI67 UTP20 PRKDC GOLGB1 NUP153 | 4.46e-07 | 1024 | 149 | 18 | 24711643 |
| Pubmed | NSF DISC1 POTEF CMAS POTEE PARP1 GTF2IRD2B TRAP1 TRMT10C GTF2I MRPL15 SUPT16H GTF2IRD2 PRKDC HSP90AB2P POTEI EIF3M NUP153 TGS1 | 5.52e-07 | 1153 | 149 | 19 | 29845934 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CFAP47 FAM47A MYH3 MYH4 ANK1 CCDC73 DISC1 BCORL1 DNAH14 RYR1 POTEE DST UTP20 ANKRD18A PRKDC | 7.06e-07 | 736 | 149 | 15 | 29676528 |
| Pubmed | CMAS GSN PARP1 GTF2I SUGP2 CEBPZ SUPT16H MKI67 UTP20 PRKDC SPATS2 NOL8 | 1.28e-06 | 483 | 149 | 12 | 36912080 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | ORC3 CMAS PARP1 TRAP1 TRMT10C GTF2I SUGP2 CEBPZ SUPT16H MKI67 UTP20 PRKDC HSP90AB2P EIF3M NUP153 KNL1 NOL8 | 1.29e-06 | 989 | 149 | 17 | 36424410 |
| Pubmed | 1.49e-06 | 20 | 149 | 4 | 33397958 | ||
| Pubmed | 1.53e-06 | 6 | 149 | 3 | 10444070 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | RBBP6 RBBP8 BCORL1 SGO1 BRAP POTEE N4BP2 UCHL1 ARID2 DIAPH3 POTEI GOLGB1 KNL1 | 1.66e-06 | 588 | 149 | 13 | 38580884 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | NUP85 ACOT9 VTA1 CPT2 CMAS POTEE HARS2 PARP1 TRAP1 TRMT10C DST AKAP9 MRPL15 OSBPL3 ARID2 SYNE2 SUPT16H SCP2 DIAPH3 SPATS2 GOLGB1 | 1.76e-06 | 1496 | 149 | 21 | 32877691 |
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 20962236 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ACOT9 CAPN2 CC2D1A EIF2S3B PDCD4 GSN PARP1 TRMT10C GTF2I CEBPZ GLG1 SYNE2 SUPT16H PRKDC HSP90AB2P DIAPH3 SPATS2 EIF3M GOLGB1 SPINK5 | 2.87e-06 | 1415 | 149 | 20 | 28515276 |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | PARP1 GTF2I SUGP2 CEBPZ UCHL1 SUPT16H MKI67 UTP20 NUP153 NOL8 | 2.90e-06 | 349 | 149 | 10 | 25665578 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RBBP6 BCORL1 EIF2S3B SMC5 PARP1 GTF2I SUGP2 CEBPZ ARID2 BRD9 SUPT16H MKI67 PRKDC NUP153 KNL1 NOL8 | 3.70e-06 | 954 | 149 | 16 | 36373674 |
| Pubmed | 3.71e-06 | 210 | 149 | 8 | 16565220 | ||
| Pubmed | 3.88e-06 | 149 | 149 | 7 | 25184681 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 3.98e-06 | 283 | 149 | 9 | 30585729 | |
| Pubmed | RBBP6 ORC3 CAPN2 MORC2 SMC5 CMAS PARP1 GTF2I SUGP2 BRD9 SUPT16H MKI67 PRKDC TAF7 EIF3M NUP153 | 7.94e-06 | 1014 | 149 | 16 | 32416067 | |
| Pubmed | 8.95e-06 | 313 | 149 | 9 | 20800603 | ||
| Pubmed | 9.05e-06 | 10 | 149 | 3 | 18434328 | ||
| Pubmed | GBF1 DGKD MORC2 SACS OSBPL3 N4BP2 ARID2 SBF2 SLITRK5 ASTN2 FHDC1 | 9.90e-06 | 493 | 149 | 11 | 15368895 | |
| Pubmed | 1.24e-05 | 11 | 149 | 3 | 18406329 | ||
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 1.34e-05 | 180 | 149 | 7 | 30110629 | |
| Pubmed | 1.40e-05 | 418 | 149 | 10 | 34709266 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ANK1 NUP85 NSF RBBP6 ORC3 ACOT9 PDCD4 PARP1 TRAP1 TRMT10C GTF2I CEBPZ BRD9 SUPT16H MKI67 PRKDC EIF3M NUP153 | 1.49e-05 | 1318 | 149 | 18 | 30463901 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.57e-05 | 123 | 149 | 6 | 26912792 | |
| Pubmed | 1.65e-05 | 12 | 149 | 3 | 21679440 | ||
| Pubmed | 1.65e-05 | 12 | 149 | 3 | 35472321 | ||
| Pubmed | 1.71e-05 | 187 | 149 | 7 | 26460568 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 12954602 | ||
| Pubmed | Investigating the genetic susceptibility to exertional heat illness. | 1.82e-05 | 2 | 149 | 2 | 32054689 | |
| Pubmed | Expression of Ki67 and CD105 as proliferation and angiogenesis markers in salivary gland tumors. | 1.82e-05 | 2 | 149 | 2 | 23244127 | |
| Pubmed | Essential role of the N-terminal region of TFII-I in viability and behavior. | 1.82e-05 | 2 | 149 | 2 | 20403157 | |
| Pubmed | Poly(ADP-ribose) polymerase 1 interacts with OAZ and regulates BMP-target genes. | 1.82e-05 | 2 | 149 | 2 | 14623329 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 21575570 | ||
| Pubmed | DNA damage-induced inhibition of rRNA synthesis by DNA-PK and PARP-1. | 1.82e-05 | 2 | 149 | 2 | 23775790 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 29149168 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 12496092 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 17259277 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 21248738 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 24013571 | ||
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 1.82e-05 | 2 | 149 | 2 | 14722100 | |
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 1.82e-05 | 2 | 149 | 2 | 19669888 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 19788614 | ||
| Pubmed | Structural and functional interactions within ryanodine receptor. | 1.82e-05 | 2 | 149 | 2 | 26009179 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 25735680 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 32899693 | ||
| Pubmed | Functional expression of transgenic 1sDHPR channels in adult mammalian skeletal muscle fibres. | 1.82e-05 | 2 | 149 | 2 | 21262876 | |
| Pubmed | Disc1 regulates granule cell migration in the developing hippocampus. | 1.82e-05 | 2 | 149 | 2 | 19502360 | |
| Pubmed | Increasing the number of diagnostic mutations in malignant hyperthermia. | 1.82e-05 | 2 | 149 | 2 | 19191329 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 9199552 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 15286704 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 22614020 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 35509066 | ||
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 1.82e-05 | 2 | 149 | 2 | 15033925 | |
| Pubmed | Ryanodine receptor-ankyrin interaction regulates internal Ca2+ release in mouse T-lymphoma cells. | 1.82e-05 | 2 | 149 | 2 | 7629097 | |
| Pubmed | DNA-dependent protein kinase promotes DNA end processing by MRN and CtIP. | 1.82e-05 | 2 | 149 | 2 | 31934630 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 23071115 | ||
| Pubmed | M-calpain levels increase during fusion of myoblasts in the mutant muscular dysgenesis (mdg) mouse. | 1.82e-05 | 2 | 149 | 2 | 10949052 | |
| Pubmed | Germline mutation rates at tandem repeat loci in DNA-repair deficient mice. | 1.82e-05 | 2 | 149 | 2 | 15450426 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 27147545 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 18556650 | ||
| Pubmed | Distinct Components of Retrograde Ca(V)1.1-RyR1 Coupling Revealed by a Lethal Mutation in RyR1. | 1.82e-05 | 2 | 149 | 2 | 26910427 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 30542613 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 12578912 | ||
| Pubmed | Impact of PARP-1 and DNA-PK expression on survival in patients with glioblastoma multiforme. | 1.82e-05 | 2 | 149 | 2 | 21775006 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 15280431 | ||
| Pubmed | Expression of the ryanodine receptor isoforms in immune cells. | 1.82e-05 | 2 | 149 | 2 | 11673493 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 12023238 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 11673462 | ||
| Pubmed | Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis. | 1.82e-05 | 2 | 149 | 2 | 9398855 | |
| Pubmed | Genetic and functional analyses identify DISC1 as a novel callosal agenesis candidate gene. | 1.82e-05 | 2 | 149 | 2 | 21739582 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 25658027 | ||
| Pubmed | CD105/Ki67 double immunostaining expression in liver metastasis from colon carcinoma. | 1.82e-05 | 2 | 149 | 2 | 21655651 | |
| Pubmed | Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain. | 1.82e-05 | 2 | 149 | 2 | 25370123 | |
| Pubmed | Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome. | 1.82e-05 | 2 | 149 | 2 | 15388857 | |
| Pubmed | Suppression of the poly(ADP-ribose) polymerase activity by DNA-dependent protein kinase in vitro. | 1.82e-05 | 2 | 149 | 2 | 10467406 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 30689883 | ||
| Pubmed | Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels. | 1.82e-05 | 2 | 149 | 2 | 18618700 | |
| Pubmed | RYR1 and CACNA1S genetic variants identified with statin-associated muscle symptoms. | 1.82e-05 | 2 | 149 | 2 | 30325262 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 23233134 | ||
| Pubmed | GBF1 MYO5A NSF RBBP8 CMAS PARP1 DST ARID2 BRD9 SUPT16H MKI67 NUP153 | 1.99e-05 | 634 | 149 | 12 | 34591612 | |
| Pubmed | MYO5A NSF CC2D1A CMAS BRAP PARP1 TRMT10C AKAP9 MRPL15 SACS CEBPZ GLG1 N4BP2 SYNE2 SUPT16H NFXL1 DIAPH3 GOLGB1 NOL8 | 2.13e-05 | 1487 | 149 | 19 | 33957083 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | NUP85 ORC3 PARP1 GTF2I CEBPZ ARID2 SUPT16H SNX18 MKI67 NUP153 | 2.17e-05 | 440 | 149 | 10 | 34244565 |
| Pubmed | ORC3 BCORL1 CC2D1A MORC2 ZEB2 GSN PARP1 GTF2I SUGP2 ARID2 BRD9 MKI67 SCP2 PRKDC NUP153 KNL1 | 2.23e-05 | 1103 | 149 | 16 | 34189442 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MYO5A RBBP6 SMC5 CMAS SUGP2 CEBPZ ARID2 SUPT16H MKI67 UTP20 PRKDC SPATS2 NOL8 | 2.53e-05 | 759 | 149 | 13 | 35915203 |
| Pubmed | 2.71e-05 | 14 | 149 | 3 | 34111398 | ||
| Pubmed | MED12 regulates a transcriptional network of calcium-handling genes in the heart. | 2.71e-05 | 14 | 149 | 3 | 28724790 | |
| Pubmed | NUP85 MYO5A NSF ORC3 GSN POTEE PARP1 AFAP1 DST SUPT16H MKI67 PRKDC | 2.95e-05 | 660 | 149 | 12 | 32780723 | |
| Interaction | ZNF783 interactions | 8.39e-07 | 11 | 146 | 4 | int:ZNF783 | |
| Interaction | NUP43 interactions | NUP85 RBBP6 RBBP8 CCDC168 MORC2 SGO1 RYR2 GTF2I DST CEBPZ ARID2 SYNE2 SUPT16H MKI67 UTP20 NUP153 KNL1 | 2.96e-06 | 625 | 146 | 17 | int:NUP43 |
| Interaction | RYR1 interactions | 1.44e-05 | 43 | 146 | 5 | int:RYR1 | |
| Interaction | CENPA interactions | ORC3 BCORL1 MORC2 PARP1 GTF2I CEBPZ BRD9 SUPT16H UTP20 PRKDC DIAPH3 NOL8 | 2.00e-05 | 377 | 146 | 12 | int:CENPA |
| Interaction | NAA40 interactions | NEBL RBBP6 CC2D1A SMC5 PDCD4 BRAP PARP1 TRAP1 GTF2I DST SUGP2 UCHL1 ARID2 SUPT16H MKI67 PRKDC GOLGB1 NUP153 KNL1 NOL8 | 2.65e-05 | 978 | 146 | 20 | int:NAA40 |
| Interaction | BRCA1 interactions | CFAP47 GBF1 NSF ORC3 RBBP8 ZNF423 TNS2 SMC5 CMAS BRAP PARP1 AFAP1 GTF2I DST FBXO5 BRD9 SUPT16H MKI67 PRKDC HSP90AB2P EIF3M NUP153 KNL1 | 3.28e-05 | 1249 | 146 | 23 | int:BRCA1 |
| Interaction | CBX2 interactions | 3.73e-05 | 126 | 146 | 7 | int:CBX2 | |
| Interaction | ACTC1 interactions | RBBP6 DISC1 POTEF GSN POTEE AFAP1 GTF2I DST UCHL1 ARID2 SYNE2 BRD9 MKI67 POTEI GOLGB1 NUP153 | 4.47e-05 | 694 | 146 | 16 | int:ACTC1 |
| Cytoband | 1q41-q42 | 1.04e-04 | 5 | 149 | 2 | 1q41-q42 | |
| Cytoband | 8q11 | 1.56e-04 | 6 | 149 | 2 | 8q11 | |
| Cytoband | 10q24 | 2.03e-04 | 35 | 149 | 3 | 10q24 | |
| Cytoband | 18q11.2 | 4.89e-04 | 47 | 149 | 3 | 18q11.2 | |
| Cytoband | 2q21.1 | 9.07e-04 | 58 | 149 | 3 | 2q21.1 | |
| GeneFamily | Ankyrin repeat domain containing | TRPV1 GLS2 ANK1 POTEF BCORL1 ANKRD18B POTEE TRANK1 ANKRD13C ANKRD18A ANKRD12 POTEI | 7.40e-09 | 242 | 98 | 12 | 403 |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 4.25e-05 | 13 | 98 | 3 | 685 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 8.69e-05 | 3 | 98 | 2 | 287 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MYO5A ORC3 RBBP8 MATN2 NAP1L3 TTLL7 TRMT10C SACS CEBPZ SYNE2 MKI67 SCP2 DIAPH3 GOLGB1 KNL1 | 4.53e-06 | 656 | 147 | 15 | M18979 |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | NUP85 DGKD PDCD4 PARP1 TRAP1 FBXO5 MRPL15 SUPT16H MKI67 UTP20 PRKDC EIF3M NUP153 TGS1 | 9.53e-06 | 612 | 147 | 14 | M4772 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL | NUP85 ORC3 RBBP8 TTC39C CC2D1A KATNA1 SMC5 SGO1 ZNF10 HARS2 TRAP1 TRMT10C FBXO5 SACS N4BP2 MKI67 CD69 DIAPH3 SPATS2 NUP153 KNL1 TGS1 | 1.49e-05 | 1423 | 147 | 22 | M45722 |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_UP | 1.80e-05 | 200 | 147 | 8 | M8836 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN | 1.80e-05 | 200 | 147 | 8 | M7418 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | NUP85 ORC3 RBBP8 TTC39C CC2D1A SMC5 SGO1 CMAS TRAP1 FBXO5 MRPL15 SUGP2 N4BP2 SYNE2 SUPT16H MKI67 PRKDC DIAPH3 SPATS2 KNL1 TGS1 | 2.50e-05 | 1363 | 147 | 21 | M45782 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | MYO5A RBBP6 SMC5 AFAP1 AKAP9 CEBPZ SYNE2 SUPT16H MKI67 PRKDC KNL1 TGS1 | 1.46e-06 | 311 | 144 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | MYO5A RBBP6 MYNN SMC5 BRAP AFAP1 AKAP9 ANKRD13C CEBPZ SYNE2 POC1B BRD9 SUPT16H MKI67 PRKDC CCDC171 KNL1 NOL8 TGS1 | 3.58e-06 | 831 | 144 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | SPATA7 MYO5A RBBP6 SMC5 AFAP1 AKAP9 ANKRD13C CEBPZ UCHL1 SYNE2 SUPT16H MKI67 SLITRK5 UTP20 PRKDC TAF7 CCDC171 KNL1 NOL8 TGS1 | 1.20e-05 | 989 | 144 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | SPATA7 RBBP8 BCORL1 SMC5 SGO1 DST AKAP9 CEBPZ SUPT16H PRKDC CEP126 NOL8 TGS1 | 1.92e-05 | 469 | 144 | 13 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 5.09e-05 | 192 | 144 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | RBBP6 ANKRD18B GTF2I AKAP9 SYNE2 ANKRD18A ANKRD12 EIF3M GOLGB1 | 2.33e-08 | 199 | 148 | 9 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.80e-07 | 193 | 148 | 8 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 3.40e-07 | 198 | 148 | 8 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | distal-Endothelial-Vein-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.53e-07 | 199 | 148 | 8 | f9fc0482d7ab11f2165b30cce3564b4ff87d61a6 | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 3.53e-07 | 199 | 148 | 8 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.79e-06 | 172 | 148 | 7 | dd9ba79e1542fe9fa2c319077d83dd3fc0158f46 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.25e-06 | 178 | 148 | 7 | ea10117026021c959ffc871fc377cdb3e161d264 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-06 | 179 | 148 | 7 | a09647750eba9d93c5efc1db3b555fefb5eec7b5 | |
| ToppCell | LPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-06 | 115 | 148 | 6 | c67145d3cd9243994a141749b426ff2a6dcc8d93 | |
| ToppCell | LPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-06 | 115 | 148 | 6 | ad5298c2ad8bf94fa13c2e50b0799e929473ef59 | |
| ToppCell | LPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-06 | 115 | 148 | 6 | 7a733f6987b40ec497a03734b79ed5355ad3a2fc | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 2.52e-06 | 181 | 148 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.71e-06 | 183 | 148 | 7 | 6f8f997ffc9eaebca2683de125b6069d07c07d26 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-06 | 183 | 148 | 7 | 52af3c943116073c8ddd207b664342960b88929b | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-06 | 187 | 148 | 7 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.12e-06 | 187 | 148 | 7 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.23e-06 | 188 | 148 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 3.35e-06 | 189 | 148 | 7 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-06 | 190 | 148 | 7 | b99271d139c8d01e20feb95d99f79c9b2756b4cb | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-06 | 193 | 148 | 7 | eba3c70701b051bc1ed1f4db9270cb27a77ffc3e | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.85e-06 | 193 | 148 | 7 | ccab6a0c76f574ef7e1d6d5f1e620376daf21bbf | |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 3.98e-06 | 194 | 148 | 7 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-06 | 194 | 148 | 7 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.98e-06 | 194 | 148 | 7 | 23318a1b55895b5166c6151f488a94a09b4627ff | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.98e-06 | 194 | 148 | 7 | 3a49c7c86036e09a8cd0114988380d04ad1a26fb | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-06 | 194 | 148 | 7 | 5d30d3d41d5f19cdf3077cc609aa2738762cb8c5 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.12e-06 | 195 | 148 | 7 | 83da75d210ae9c2a94018d70cb9e833b37004c4e | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.12e-06 | 195 | 148 | 7 | 5790b47b0e028e49b99bda8d6d9e80ac79208cdf | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_Tcm|World / disease group, cell group and cell class (v2) | 4.12e-06 | 195 | 148 | 7 | a72bb5b1b15dd1ab70ced5622d94499caff8bb6b | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 4.12e-06 | 195 | 148 | 7 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.12e-06 | 195 | 148 | 7 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 4.40e-06 | 197 | 148 | 7 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.40e-06 | 197 | 148 | 7 | 196eaecef7003ed83f323c1f157c6a3594650097 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 4.40e-06 | 197 | 148 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 4.40e-06 | 197 | 148 | 7 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.40e-06 | 197 | 148 | 7 | 56afed433887cb2766eb30f22aec195148db33ab | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.55e-06 | 198 | 148 | 7 | e36303628af3139310c1d7a84d2919b7319bbda4 | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 4.55e-06 | 198 | 148 | 7 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.55e-06 | 198 | 148 | 7 | f5b7013045b61fc56894f80092f799770dde1c8f | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.55e-06 | 198 | 148 | 7 | 844f534551483c89ef789d1cfeb4680e54f794b2 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.55e-06 | 198 | 148 | 7 | 7225a6194c52b01c581e58d3cda107c4af96dc4f | |
| ToppCell | NS-critical-d_16-33-Lymphoid-NKT-proliferating|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.70e-06 | 199 | 148 | 7 | 31b144bb209c629e12156f4d9c9cec79baffffb9 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.70e-06 | 199 | 148 | 7 | 8e7f9312dec1e3a92b6a0ccc7baa2d46e89c11f3 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 4.70e-06 | 199 | 148 | 7 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 4.70e-06 | 199 | 148 | 7 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.70e-06 | 199 | 148 | 7 | cdee798e3586e4e7a15de598239090a85752ea1e | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 4.70e-06 | 199 | 148 | 7 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 4.70e-06 | 199 | 148 | 7 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.70e-06 | 199 | 148 | 7 | fe3b7d540a644dfc6beea171c809b4d1ba4e188f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 4.86e-06 | 200 | 148 | 7 | 31dd81df9aa754a1e69b905bf9b8ce73ff8175aa | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.86e-06 | 200 | 148 | 7 | dd5b753bb1333fa502b9d3a6d65a53a9882b2451 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells-Neuroepithelial_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 4.86e-06 | 200 | 148 | 7 | 54174a485a82480726fa06efa6e050ddea77cb3c | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_only / Treatment groups by lineage, cell group, cell type | 4.86e-06 | 200 | 148 | 7 | 83c4181c083b364f0d3a89ae7a0504781fa9fa9f | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_only / Treatment groups by lineage, cell group, cell type | 4.86e-06 | 200 | 148 | 7 | f15baf287ec467664c23faa53fdea45257f7b9d0 | |
| ToppCell | distal-3-Endothelial-Vein|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.86e-06 | 200 | 148 | 7 | 3a5c85bad2e7a9ecf55d90acb04178a343b3f5fd | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary|LPS_only / Treatment groups by lineage, cell group, cell type | 4.86e-06 | 200 | 148 | 7 | ce8281c9556a1f64f8ca8a029110077d4ef5b35e | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Mast|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-05 | 151 | 148 | 6 | 9702575e47ececcf0a9f0f20a4a920dbb1ba5657 | |
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma|TCGA-Uterus / Sample_Type by Project: Shred V9 | 1.15e-05 | 151 | 148 | 6 | 2810bfa01bd3016aeba29735eb4a9284792e8aac | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-05 | 151 | 148 | 6 | 673e4ab117b723c14d1df3804bbedc9e48284a9d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-05 | 152 | 148 | 6 | 5adcdf93fd3ca066402aaaf308c363e4648f871d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.60e-05 | 160 | 148 | 6 | 33050dc646762dc7e9dcc4a12c618e1ba1ce5a4d | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.66e-05 | 161 | 148 | 6 | c61283c301a87bb802f6f8ce79c26067032dd7d9 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.66e-05 | 161 | 148 | 6 | 9864d8b0929dacf4be7a4e97d2527ac3120ea264 | |
| ToppCell | droplet-Fat-Gat-18m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 164 | 148 | 6 | 7dbe34a98a3b475c1ba678db8a5494c0c6a91e2d | |
| ToppCell | droplet-Fat-Gat-18m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 164 | 148 | 6 | febcb8f8b305aa94e21131fa83d2890f7a6838fc | |
| ToppCell | droplet-Fat-Gat-18m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-05 | 165 | 148 | 6 | 1e89154114327650df39befb2c56d0379ea6a221 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-05 | 167 | 148 | 6 | 754e6412d3b9cc0b126e59593df2f5956b4712ef | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 169 | 148 | 6 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 170 | 148 | 6 | 8fe32dcf924d5f6665f7febbc9647d96b1e96f06 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.25e-05 | 170 | 148 | 6 | 6b91d4cbe0697b65bfb2e099e7a9b39ea2fba3a9 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 170 | 148 | 6 | 3232db50b1a40f861e981a1b9c9073b81af9f832 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 170 | 148 | 6 | 50c6c571591aa4b218caefe5778c570c809f567e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.25e-05 | 170 | 148 | 6 | cf22a843ae2d9cd6693507fed2b7c6a45abea10e | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 171 | 148 | 6 | ff117bf1a0755aa7d7c3db29749a7b9b90cc0b2f | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 172 | 148 | 6 | 3f784aed340b50ddbec3f7dc0a5279180d38a2bb | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 172 | 148 | 6 | db5a31cafce4346fe459d7f35210823fd7004439 | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 172 | 148 | 6 | 24ecfda5e43e28f190089770cd2eae5bf2ed292b | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 172 | 148 | 6 | 95219814e37259e34be053572cc95d4639360c27 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 173 | 148 | 6 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 173 | 148 | 6 | a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.57e-05 | 174 | 148 | 6 | b43fb0fbb492c1be6e791a1c4d6c4e5956955ee4 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.57e-05 | 174 | 148 | 6 | 94575a605c725de83f66a6cf7df9d7bb360ffc56 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.57e-05 | 174 | 148 | 6 | 40c81ab36d7931e271e20d7d56fed32463c75f41 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.65e-05 | 175 | 148 | 6 | 15c69dd5635c9251c535f1e22467712e9667ae92 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.74e-05 | 176 | 148 | 6 | 45c6983ab671b0f306e7390320bd84f848e474cc | |
| ToppCell | COVID-19-Myeloid-MoAM4|COVID-19 / Condition, Lineage and Cell class | 2.83e-05 | 177 | 148 | 6 | ca5d0c3d5c700bbe4c2da068eb02be6229afb9a0 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.83e-05 | 177 | 148 | 6 | 26c25d10aa511b64cc7db43a8deea7b5d31bca96 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-05 | 177 | 148 | 6 | e9d7682517fb30fd2ad535d59779d718a7024c13 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.83e-05 | 177 | 148 | 6 | 8a74f5e72de605774111057bd87a7e7e4a6385cd | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.83e-05 | 177 | 148 | 6 | 3081ce5fc66a1bb833719d6c0e0a6fc7115eeb91 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-05 | 177 | 148 | 6 | 8a0f0fbb06cdacb99a3fdba0da3e0494b891db4f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-05 | 179 | 148 | 6 | 8f9e538c822940785130297712b75131812a4603 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.01e-05 | 179 | 148 | 6 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 179 | 148 | 6 | 54621d2b3a66e62aa76b7e444118878ed97c1e02 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.01e-05 | 179 | 148 | 6 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.11e-05 | 180 | 148 | 6 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | Healthy_Control-Lymphoid-T-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.20e-05 | 181 | 148 | 6 | ac1ee313910c05b1b3cb497bae14565464919c21 | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 3.20e-05 | 181 | 148 | 6 | b6b41cd5d43543fe7a093033dae52a789199db0e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.20e-05 | 181 | 148 | 6 | c35ca98c474e31917e0a53c092397e0d8d18b37c | |
| ToppCell | droplet-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 182 | 148 | 6 | cfba75c1ffc39ac76db9e8e27394731942882b30 | |
| Computational | Genes in the cancer module 202. | 2.08e-06 | 28 | 83 | 5 | MODULE_202 | |
| Drug | chloro-m-cresol | 5.20e-06 | 6 | 147 | 3 | CID000012008 | |
| Drug | NSC114784 | 5.20e-06 | 6 | 147 | 3 | CID000419425 | |
| Drug | AC1N9ZZC | 5.76e-06 | 149 | 147 | 8 | CID004369374 | |
| Drug | Acrylamide | 6.05e-06 | 199 | 147 | 9 | ctd:D020106 | |
| Disease | Malignant hyperthermia, susceptibility to | 2.37e-05 | 2 | 144 | 2 | cv:C5437603 | |
| Disease | Malignant hyperthermia | 2.37e-05 | 2 | 144 | 2 | cv:C5779784 | |
| Disease | Malignant hyperpyrexia due to anesthesia | 2.37e-05 | 2 | 144 | 2 | C0024591 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 4.96e-05 | 15 | 144 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (is_implicated_in) | 7.07e-05 | 3 | 144 | 2 | DOID:8545 (is_implicated_in) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 7.07e-05 | 3 | 144 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 7.07e-05 | 3 | 144 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Multiple pterygium syndrome | 1.41e-04 | 4 | 144 | 2 | C0265261 | |
| Disease | Rare disease with malignant hyperthermia | 1.41e-04 | 4 | 144 | 2 | cv:C5681128 | |
| Disease | Malignant neoplasm of breast | ANK1 BCORL1 ZEB2 PDCD4 GSN PARP1 AKAP9 N4BP2 SYNE2 MKI67 SCP2 UTP20 ASTN2 EIF3M GOLGB1 | 2.54e-04 | 1074 | 144 | 15 | C0006142 |
| Disease | Digitotalar Dysmorphism | 3.50e-04 | 6 | 144 | 2 | C1852085 | |
| Disease | ARTHROGRYPOSIS, DISTAL, TYPE 1 | 3.50e-04 | 6 | 144 | 2 | C0220662 | |
| Disease | granulocyte colony-stimulating factor measurement | 6.10e-04 | 34 | 144 | 3 | EFO_0008142 | |
| Disease | pulse pressure measurement, diastolic blood pressure, systolic blood pressure, hypertension | 6.64e-04 | 35 | 144 | 3 | EFO_0000537, EFO_0005763, EFO_0006335, EFO_0006336 | |
| Disease | myeloid white cell count | JCAD TRAF1 ERG ZNF423 NAIP VTA1 PTK2B TRAP1 GLG1 SBF2 CD69 RMC1 TGS1 | 7.04e-04 | 937 | 144 | 13 | EFO_0007988 |
| Disease | amyotrophic lateral sclerosis | 7.44e-04 | 145 | 144 | 5 | MONDO_0004976 | |
| Disease | Distal arthrogryposis | 8.33e-04 | 9 | 144 | 2 | cv:C0265213 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.04e-03 | 10 | 144 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.04e-03 | 10 | 144 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.04e-03 | 10 | 144 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.04e-03 | 10 | 144 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.04e-03 | 10 | 144 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.04e-03 | 10 | 144 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.04e-03 | 10 | 144 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.04e-03 | 10 | 144 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | congestive heart failure (implicated_via_orthology) | 1.06e-03 | 41 | 144 | 3 | DOID:6000 (implicated_via_orthology) | |
| Disease | subiculum volume | 1.22e-03 | 43 | 144 | 3 | EFO_0009399 | |
| Disease | rotator cuff tear, shoulder impingement syndrome | 1.51e-03 | 12 | 144 | 2 | EFO_1001178, EFO_1001250 | |
| Disease | phenylacetylglutamine measurement | 1.51e-03 | 12 | 144 | 2 | EFO_0021013 | |
| Disease | distal myopathy (implicated_via_orthology) | 1.51e-03 | 12 | 144 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.51e-03 | 12 | 144 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | Congenital myopathy (disorder) | 1.51e-03 | 12 | 144 | 2 | C0270960 | |
| Disease | lymphocyte percentage of leukocytes | CACNA1S TRAF1 GBF1 ERG ANK1 GRK5 GTF2IRD2B GTF2IRD2 CD69 PRKDC | 1.63e-03 | 665 | 144 | 10 | EFO_0007993 |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.78e-03 | 13 | 144 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | colonic neoplasm, overall survival | 2.07e-03 | 14 | 144 | 2 | EFO_0000638, EFO_0004288 | |
| Disease | brain aneurysm | 2.32e-03 | 113 | 144 | 4 | EFO_0003870 | |
| Disease | Peripheral Nervous System Diseases | 2.35e-03 | 54 | 144 | 3 | C4721453 | |
| Disease | isoleucine measurement | 2.61e-03 | 56 | 144 | 3 | EFO_0009793 | |
| Disease | Varicose veins | 2.63e-03 | 193 | 144 | 5 | HP_0002619 | |
| Disease | pancreatitis | 2.71e-03 | 16 | 144 | 2 | EFO_0000278 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.75e-03 | 195 | 144 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | waist-hip ratio | JCAD GLS2 NUP85 ZNF423 KCNB2 SBF2 SYNE2 POC1B CDYL2 ASTN2 HSP90AB2P RMC1 CCDC171 KNL1 | 2.76e-03 | 1226 | 144 | 14 | EFO_0004343 |
| Disease | cleft lip | 2.78e-03 | 284 | 144 | 6 | EFO_0003959 | |
| Disease | FEV/FEC ratio | JCAD NEBL VTA1 DGKD ZEB2 AFAP1 GTF2I DST SBF2 SYNE2 ASTN2 HSP90AB2P TAF7 CCDC171 | 2.80e-03 | 1228 | 144 | 14 | EFO_0004713 |
| Disease | pre-eclampsia (is_marker_for) | 2.89e-03 | 58 | 144 | 3 | DOID:10591 (is_marker_for) | |
| Disease | adverse effect, response to xenobiotic stimulus | 3.03e-03 | 59 | 144 | 3 | EFO_0009658, GO_0009410 | |
| Disease | taste liking measurement | 3.04e-03 | 388 | 144 | 7 | EFO_0010155 | |
| Disease | hippocampal volume | 3.46e-03 | 297 | 144 | 6 | EFO_0005035 | |
| Disease | kidney failure (biomarker_via_orthology) | 3.83e-03 | 19 | 144 | 2 | DOID:1074 (biomarker_via_orthology) | |
| Disease | Cannabis use, age at onset | 3.83e-03 | 19 | 144 | 2 | EFO_0004847, EFO_0007585 | |
| Disease | breast carcinoma | NEBL NSF RBBP8 GTF2IRD2B GTF2I AKAP9 GLG1 SBF2 GTF2IRD2 CDYL2 ASTN2 MYBPC1 | 4.33e-03 | 1019 | 144 | 12 | EFO_0000305 |
| Disease | mean platelet volume | JCAD GLS2 MYO5A GRK5 BCORL1 RGS3 AFAP1 TRANK1 SYNE2 TAF7 ICA1L TGS1 | 4.36e-03 | 1020 | 144 | 12 | EFO_0004584 |
| Disease | susceptibility to mononucleosis measurement | 4.71e-03 | 69 | 144 | 3 | EFO_0008403 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MLVSCKKLTEIKFSD | 1176 | Q13075 | |
| MKTKFKETIEKCDNL | 441 | Q7Z569 | |
| SKDCVLTISEEMFSK | 1541 | Q99996 | |
| KEDKSCSITKSKMHV | 66 | Q5JVX7 | |
| KELTLKDVECKFSKM | 866 | Q8IVF6 | |
| DCTLVSETVLLKMKK | 691 | Q99708 | |
| KSVTEFKADFKLMCD | 196 | Q9H8M2 | |
| ASMDLVKDAKICAFL | 146 | Q8N556 | |
| ALLEKEASQACMTKK | 521 | P16157 | |
| KKVEKLETEHMDCSD | 236 | Q6TFL3 | |
| KELCKMTKDDFQRLT | 166 | P11308 | |
| KCKTKHMATVSEEAK | 1421 | Q5H9F3 | |
| VACTKIAKVEKSIDM | 431 | Q68CP9 | |
| VCKESKKTFKATIAM | 441 | Q8N6S4 | |
| ELTLKDVECKFSKMK | 876 | A2A2Z9 | |
| TALVDKIDMCKKSLS | 146 | Q9Y305 | |
| PTFENSDCTLKKMDK | 631 | Q6UB98 | |
| MAVSTACEEIKKSKS | 821 | Q9NSV4 | |
| FIESKKDDILCFLTM | 221 | Q8IVL8 | |
| SLKEITTKVCMSEKF | 556 | Q9NRI5 | |
| MSEKFCSTLRKKVND | 566 | Q9NRI5 | |
| IASMILKSDEKLFKC | 656 | Q8N608 | |
| TKCADDAMTLVLKKE | 361 | P17813 | |
| YSILKDTKITCEEKM | 1311 | O75129 | |
| MKKEVCSVAFLKAVF | 1 | P55064 | |
| KEKFDATMKTLTIDC | 431 | P23786 | |
| ESVKCDLEKSMKAGL | 316 | O75901 | |
| CEDFKKVKSQSKMAS | 1106 | P49796 | |
| ASLCISTKKEVEKMN | 426 | P09874 | |
| DKCVFLKNTEVSSME | 171 | Q07108 | |
| DKKTMKLDECFQIFR | 436 | Q9C0D6 | |
| VVEKMNSELSLSCKK | 626 | A5A3E0 | |
| SKKKVCEKLSVEEEM | 426 | Q6ZWB6 | |
| ETCFSKKKLMKEVDT | 76 | Q3ZCV2 | |
| STMDEISEKLKKGIC | 821 | O00339 | |
| MFKKFDEKESVSNCI | 1 | A0A3B3IRV3 | |
| IECDTTCKEMKRKAS | 821 | Q6ZNB6 | |
| SEKSTMEQLVEKACF | 1101 | Q86WG5 | |
| MCASVFKLEEEEKKN | 531 | Q9NQ38 | |
| MEDTIKEKKEAVTSC | 4356 | Q03001 | |
| AKFENLCKFMKETLD | 331 | Q58FF8 | |
| SKKKMNETIFCLVSI | 571 | Q9P266 | |
| ALVDCKKSDAASKVM | 171 | Q7L2H7 | |
| KDTLEFTMASRDACK | 251 | Q6ZUT3 | |
| MSTTDVEKSFDKLLK | 231 | Q53EL6 | |
| EMLVCETSFNKKEKS | 31 | Q9BW27 | |
| KFEAFCKRLEKITEM | 361 | Q96JB1 | |
| EVVTKCKIKMEDFAF | 106 | Q9NPC7 | |
| KKIDNCLTEMETETK | 2046 | Q8NG31 | |
| FSETAKCQAMKKIFD | 576 | P46459 | |
| SLIKMDCNKAEKFDF | 276 | Q9UI32 | |
| EESMTDEKTTKIACK | 1116 | P46013 | |
| TKKKTEDMSDLPCES | 406 | Q8TC44 | |
| AEADLKKCMSVLNKT | 61 | Q76FK4 | |
| MEDTKESNVKTFCSK | 1 | P49961 | |
| SCFSHLMKSEKKVVV | 196 | P34949 | |
| VDKDFESSSMKISKL | 1156 | Q7Z6E9 | |
| ILFTKKEDTMTCLFL | 116 | Q9Y6X9 | |
| VVEKMNSELSLSCKK | 626 | Q6S8J3 | |
| KCLFNHKFEESMSEK | 336 | Q92896 | |
| TCKQETRMKKDDSTK | 41 | A8MPY1 | |
| VSEVKKDSSQEGCKM | 871 | Q92953 | |
| KGKFFRCTDLSKMTE | 951 | Q13698 | |
| CKEESSTLSVKMKCD | 36 | Q9UKT4 | |
| SFMTELLESCEKKES | 151 | Q96RJ6 | |
| MKDKELFACESAVKD | 296 | Q9BPX7 | |
| MFVLDKKCEKTSETS | 376 | Q9P2H0 | |
| VHMKTCTETEFSNKK | 796 | Q6ZRK6 | |
| MEKKECPEKSSSSEE | 1 | Q9Y2G2 | |
| TTKFEKLAEDCKRSM | 606 | Q6P1N0 | |
| MAGTKKREFKCDTSD | 1321 | Q0VDD8 | |
| ESEVMAKKCSVLKEK | 531 | Q16760 | |
| KVKECSSELKYSMEL | 646 | Q5JRC9 | |
| IKQCDPEKMITESKF | 1111 | Q92538 | |
| TICAKSLAVKAEAMK | 191 | Q86W47 | |
| DFEMALKKVSKSVSA | 461 | O75449 | |
| KAALKTASDFITKMD | 356 | P06396 | |
| VSKDSEGKLMCKSIF | 301 | Q2VIR3 | |
| EGKLMCKSIFSKIVS | 306 | Q2VIR3 | |
| SEKEIIFNAKCLTMK | 2286 | Q8NDH2 | |
| IFNAKCLTMKEKKSS | 2291 | Q8NDH2 | |
| AAKCLKEDMLKDSNT | 156 | Q5M9N0 | |
| KDCTLDNKEKFMSEA | 461 | Q14289 | |
| KFSEEAKSICKMLLT | 411 | P34947 | |
| ESMCKELAKSKAEVA | 31 | Q86UP8 | |
| ESMCKELAKSKAEVA | 31 | Q6EKJ0 | |
| ESMCKELAKSKAEVA | 31 | P78347 | |
| ASFDKLKMDVCQKVD | 196 | Q8NDH6 | |
| DIKSDGFSIETCKIM | 566 | P17655 | |
| VLKEAAKLMKTCSSS | 1731 | Q9NZJ4 | |
| ASNKEKEMITSLFCK | 3031 | P21817 | |
| LMDKEKADVKSTAFT | 316 | Q92736 | |
| ASNKEKEMVTSLFCK | 2996 | Q92736 | |
| FNSICKASTKKVVMK | 516 | Q6ZTR5 | |
| TCVKKKDVESKMLSA | 471 | Q03701 | |
| MSVKKSSKCIDLDTE | 106 | Q9H4L5 | |
| DELMTILEKCFKVFK | 466 | Q9UBD5 | |
| MKLACADTTIKEFIT | 186 | P0C629 | |
| PCVMESLKTIDKKTF | 71 | Q15545 | |
| KTSKIKSSGECVLEM | 2096 | O75691 | |
| KFRAICSSIDKLDKM | 231 | P49590 | |
| DITKDELFKMLCTRK | 246 | Q9P015 | |
| IKMSLEEKSRDVCAK | 911 | Q8WXH0 | |
| ISVSKCNKETVAMKE | 291 | Q6UWF7 | |
| SLKLDCKMEVSVSDK | 336 | Q8NFW8 | |
| MAKERCLKKSFQDSL | 1 | Q5FBB7 | |
| TVSKAKANFEKMCRT | 1241 | Q9Y623 | |
| MESVSKSKANLEKIC | 1236 | P11055 | |
| KAEEKADSKDCMEAT | 231 | Q99457 | |
| VVEKMNSELSLSCKK | 626 | P0CG38 | |
| AKKEKDMRKCDSSQT | 331 | Q8WU08 | |
| KKADCTITMADSDFL | 491 | P22307 | |
| SSFDKMIEAIKESKN | 116 | Q9Y5B9 | |
| EDKQCTTTKDILSMK | 116 | Q8NEL0 | |
| KEMASCSAVVLEESK | 446 | Q8N8U2 | |
| SDMECKITTSKDQKK | 2276 | A4UGR9 | |
| MAEKKLADCEKTAVE | 41 | Q75MW2 | |
| SIKKMKQAFAELESC | 266 | Q86XZ4 | |
| INMCESKEKTFFKLI | 11 | Q9NS28 | |
| ICKAPKKFAETDMRS | 591 | O94991 | |
| ILDTEKSFLKCMRKA | 706 | Q8NER1 | |
| MDDKGEVKCIKFSLE | 61 | Q96DM3 | |
| SKTPECRKFLSKLMD | 51 | Q9NP79 | |
| SKIDGFKCFTKKMDD | 426 | Q96RF0 | |
| VMEKSKSKISNECEV | 166 | Q9NYB5 | |
| ELETETCAKMLASFK | 356 | Q8IX01 | |
| FTEKCKQMCVISKES | 276 | Q6P2S7 | |
| KQMCVISKESDRTFE | 281 | Q6P2S7 | |
| ESEEKFKEKTKCMIN | 606 | P78562 | |
| VKDDTMFLKCIVETS | 401 | Q13077 | |
| CEKEFKLTKTAMRAN | 96 | Q9P0W8 | |
| APFTCKTSEAKKEEM | 1061 | P49790 | |
| MEDKFIVCLNKVTKS | 2356 | P78527 | |
| SIFKDKQSCDIKMEG | 101 | P21506 | |
| AMKKKDTEVLFCFEQ | 516 | Q12931 | |
| TAEKKLADCEKMAVE | 71 | Q9UDV6 | |
| MAEKKLADCEKTAVE | 41 | Q6NUN9 | |
| LAKSEKEAKKDDFMC | 251 | Q2M1K9 | |
| DKNDEKCMKVDLVSF | 281 | Q96RS0 | |
| VSSCKKLKVDMKDVT | 2331 | Q9BXT5 | |
| EKMQLACDDLKTTEK | 81 | Q8N584 | |
| VSRQKMDCKAEEISK | 471 | O60315 | |
| EIECTSEMLKKLSSK | 791 | O15050 | |
| ETSCKEKTEYLQKMV | 226 | Q8IY18 | |
| DDMLKKTTTGVKSCE | 91 | Q8N7K0 | |
| ELKTLMECVSNTAKK | 116 | Q7L0Y3 | |
| TLTMRKFCEDKVATE | 261 | Q63HR2 | |
| CEIDDEKLMGKTTKT | 511 | Q6ZT98 | |
| TEKMSPEDRAKCFEK | 121 | P09936 | |
| LEAKTCFRKMEESSL | 236 | Q5H9K5 | |
| ETLSKKFQSLMSEKD | 1736 | Q14789 | |
| SEMKNLKKCVSELEE | 1956 | Q14789 | |
| VKKKTDDDAEAICSM | 1756 | Q9Y4I1 | |
| RETLMFEKDCATKLK | 1511 | Q86UW6 | |
| FDLCKETTFEPKKMI | 671 | Q00872 | |
| EEFKKSKDKCTFVTD | 56 | O76041 |